November 29, 1999

1 Min Read
Quigley, QVC Settle FTC Charges

WASHINGTON--Quigley Corp., manufacturers of Cold-Eeze brand zinc lozenges, and the QVC home shopping network have finally settled federal charges regarding label claims. The settlement requires that the company and the network can no longer promote the benefits of the lozenges without adequate scientific evidence to support them.

According to the Federal Trade Commission (FTC), the product has been advertised with unsubstantiated claims that said it could prevent colds, relieve allergy and hay fever symptoms, reduce the risk of contracting pneumonia and reduce the severity of cold symptoms in children. The claims were made on the labels, on the Internet, in radio advertising and during the course of programming on QVC.

According to FTC director of consumer protection, Jodie Bernstein, this settlement comes at an opportune time. "With the cold and flu season fast approaching, many consumers are looking for products to help them stay healthy or feel better," she said. This settlement "will help remind marketers of their responsibility to back up all advertising claims."

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like